Center for Brain Tumor Therapy. In such capacity, up to $20M in unrestricted funds are available to Drs. Mitchell and Friedman to support clinical research activities. The capacity to support unforeseen budget shortfalls from the clinical trial award supporting this protocol is an additional administrative role that Dr. Friedman would facilitate in collaboration with Dr.